Between 2021–2024, the Krannert Cardiovascular Research Center at Indiana University School of Medicine has grown in its capacity to secure federal grants, deliver impactful cardiovascular research and publish peer reviewed articles in high-impact journals.
"I am happy to share that our investigators have expanded that knowledge, with new diagnostic tools and information, that will help shape and influence cardiovascular clinical care in the years ahead," said Rohan Dharmakumar, PhD, executive director of the Krannert Cardiovascular Research Center at IU School of Medicine. "We added more than 30 faculty members across multiple disciplines, including cardioinformatics, cardiopulmonary research, equity research, electrophysiology, ischemic heart disease, microcirculation and myocardial regenerative biology."
In 2023, IU Krannert increased its National Institutes of Health research funding from $1.1 million annually, to more than $22 million annually. Through its expanded research portfolio, IU Krannert investigators authored more than 407 publications, 80 of which had a greater than 10 impact factor. They also expanded their reach across the globe with more than 30 collaboration sites.
Other signature achievements included:
-
Revamping our cardiovascular clinical trials research program
-
Hosting the two-day Krannert Biennial, which brought more than 20 renowned cardiovascular researchers to Indianapolis from around the world
-
Launching the first-in-human FDA-approved investigative clinical trial targeting ST Elevation Myocardial Infarction
-
Introducing the world's first classification of heart attacks based on tissue damage, which was adopted by the Canadian Cardiovascular Society
"Much of our success is due to the dedication of our investigative team, students and staff, who aspire to advance cardiovascular research and clinical care to benefit the next generation, as well as the many partners and collaborators we have located worldwide," Dharmakumar said.
Ischemic Heart Disease Research Team Collaborations Around the World
